@article{ref1,
title="Intimate partner violence after cancer diagnosis: an SOS call",
journal="Supportive care in cancer",
year="2023",
author="Mejri, Nesrine and Lajnef, Ines and Berrazega, Yosra and Rachdi, Haifa and Bohli, Mariem and Kochbati, Lotfi and Hamouda, Boussen",
volume="31",
number="2",
pages="e103-e103",
abstract="PURPOSE: The aim of the present study was to measure the frequency and types of IPV among patients with cancer and evaluate risk factors. <br><br>METHODS: The study was a cross-sectional, questionnaire-based study, conducted between January and April 2022, including 141 patients treated with cancer regardless of gender, site, or stage. We developed the study questionnaire by adapting items from the &quot;WHO multi-country questionnaire on violence against women&quot; and &quot;The Women's Experiences with Battering Scale.&quot; Odds ratio (OR) and spearman tests were performed to assess the impact of several factors associated with the reported IPV. <br><br>RESULTS: Median age was 50 years old, 38.3% were male cancer patients. IPV prevalence was 24.8%, we observed 5 cases of torture (3%). The most common forms of violence were placing severe restriction on certain types of food and clothing in 21%, psychological violence in 20%, exposing intimate information about the patient health status to others in 17%, ignoration in 13.5%, putting restrictions on visiting friends or families in 9.2%, verbal assault in 9.2%, physical violence in 7.9%, and 7.1% racist conducts. Financial violence was rare in 4.3%. There was no difference in the incidence of IPV between man and women. We observed a significant correlation between IPV prevalence and disease stage (19.1% M0 vs 34.6% M1, p=0.04, OR=2.2 [1-4.8]), patient's educational level (48.5% vs 17.6%, p=0.01, OR= 4.4 [1.8-10.2]), and being under ongoing cancer therapy (11.4% vs 30.9%, p=0.013, OR=3.4 [1.2-9.7]) CONCLUSION: Patients were shown to be victims of several forms of IPV regardless of gender.<p /> <p>Language: en</p>",
language="en",
issn="0941-4355",
doi="10.1007/s00520-022-07571-9",
url="http://dx.doi.org/10.1007/s00520-022-07571-9"
}